STAAR Surgical PE Ratio 2012-2026 | STAA
Current and historical p/e ratio for STAAR Surgical (STAA) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. STAAR Surgical PE ratio as of May 15, 2026 is 0.00.
| STAAR Surgical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-05-15 | 32.07 | 0.00 | |
| 2026-03-31 | 18.70 | $-0.42 | 0.00 |
| 2025-12-31 | 23.09 | $-1.62 | 0.00 |
| 2025-09-30 | 26.87 | $-1.95 | 0.00 |
| 2025-06-30 | 16.78 | $-1.93 | 0.00 |
| 2025-03-31 | 17.63 | $-1.44 | 0.00 |
| 2024-12-31 | 24.29 | $-0.41 | 0.00 |
| 2024-09-30 | 37.15 | $0.44 | 84.43 |
| 2024-06-30 | 47.61 | $0.34 | 140.03 |
| 2024-03-31 | 38.28 | $0.31 | 123.48 |
| 2023-12-31 | 31.21 | $0.43 | 72.58 |
| 2023-09-30 | 40.18 | $0.41 | 98.00 |
| 2023-06-30 | 52.57 | $0.52 | 101.10 |
| 2023-03-31 | 63.95 | $0.66 | 96.89 |
| 2022-12-31 | 48.54 | $0.80 | 60.68 |
| 2022-09-30 | 70.55 | $0.83 | 85.00 |
| 2022-06-30 | 70.93 | $0.74 | 95.85 |
| 2022-03-31 | 79.91 | $0.65 | 122.94 |
| 2021-12-31 | 91.30 | $0.56 | 163.04 |
| 2021-09-30 | 128.53 | $0.46 | 277.60 |
| 2021-06-30 | 152.50 | $0.42 | 360.52 |
| 2021-03-31 | 105.41 | $0.22 | 472.69 |
| 2020-12-31 | 79.22 | $0.12 | 660.17 |
| 2020-09-30 | 56.56 | $0.19 | 302.46 |
| 2020-06-30 | 61.54 | $0.16 | 391.97 |
| 2020-03-31 | 32.26 | $0.27 | 120.82 |
| 2019-12-31 | 35.17 | $0.30 | 117.23 |
| 2019-09-30 | 25.78 | $0.19 | 135.68 |
| 2019-06-30 | 29.38 | $0.17 | 172.82 |
| 2019-03-31 | 34.19 | $0.13 | 263.00 |
| 2018-12-31 | 31.91 | $0.11 | 290.09 |
| 2018-09-30 | 48.00 | $0.07 | 685.71 |
| 2018-06-30 | 31.00 | $0.07 | 442.86 |
| 2018-03-31 | 14.80 | $0.01 | 0.00 |
| 2017-12-31 | 15.50 | $-0.05 | 0.00 |
| 2017-09-30 | 12.45 | $-0.05 | 0.00 |
| 2017-06-30 | 10.80 | $-0.12 | 0.00 |
| 2017-03-31 | 9.80 | $-0.15 | 0.00 |
| 2016-12-31 | 10.85 | $-0.30 | 0.00 |
| 2016-09-30 | 9.40 | $-0.32 | 0.00 |
| 2016-06-30 | 5.51 | $-0.32 | 0.00 |
| 2016-03-31 | 7.39 | $-0.31 | 0.00 |
| 2015-12-31 | 7.14 | $-0.17 | 0.00 |
| 2015-09-30 | 7.76 | $-0.20 | 0.00 |
| 2015-06-30 | 9.66 | $-0.23 | 0.00 |
| 2015-03-31 | 7.43 | $-0.24 | 0.00 |
| 2014-12-31 | 9.11 | $-0.22 | 0.00 |
| 2014-09-30 | 10.63 | $-0.18 | 0.00 |
| 2014-06-30 | 16.80 | $-0.10 | 0.00 |
| 2014-03-31 | 18.80 | $-0.04 | 0.00 |
| 2013-12-31 | 16.19 | $0.01 | 0.00 |
| 2013-09-30 | 13.54 | $-0.02 | 0.00 |
| 2013-06-30 | 10.15 | $-0.03 | 0.00 |
| 2013-03-31 | 5.63 | $-0.05 | 0.00 |
| 2012-12-31 | 6.10 | $-0.05 | 0.00 |
| 2012-09-30 | 7.56 | $0.01 | 756.00 |
| 2012-06-30 | 7.77 | $0.01 | 777.00 |
| 2012-03-31 | 10.83 | $0.04 | 270.75 |
| 2011-12-31 | 10.49 | $0.04 | 262.25 |
| 2011-09-30 | 7.80 | $0.01 | 780.00 |
| 2011-06-30 | 5.30 | $-0.02 | 0.00 |
| 2011-03-31 | 5.57 | $-0.09 | 0.00 |
| 2010-12-31 | 6.10 | $0.00 | 0.00 |
| 2010-09-30 | 5.41 | $-0.01 | 0.00 |
| 2010-06-30 | 5.72 | $-0.04 | 0.00 |
| 2010-03-31 | 3.82 | $-0.03 | 0.00 |
| 2009-12-31 | 3.10 | $-0.19 | 0.00 |
| 2009-09-30 | 4.08 | $-0.48 | 0.00 |
| 2009-06-30 | 2.41 | $-0.50 | 0.00 |
| 2009-03-31 | 1.00 | $-0.55 | 0.00 |
| 2008-12-31 | 2.38 | $-0.79 | 0.00 |
| 2008-09-30 | 4.49 | $-0.61 | 0.00 |
| 2008-06-30 | 3.10 | $-0.66 | 0.00 |
| 2008-03-31 | 2.58 | $-0.73 | 0.00 |
| 2007-12-31 | 2.64 | $-0.57 | 0.00 |
| 2007-09-30 | 3.00 | $-0.65 | 0.00 |
| 2007-06-30 | 3.82 | $-0.63 | 0.00 |
| 2007-03-31 | 5.51 | $-0.60 | 0.00 |
| 2006-12-31 | 7.01 | $-0.60 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.309B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |